Connecting the
Diabetes, Obesity, Metabolism and Complications Community
at Michigan
|
|
Welcome New CDI Managing Director
Dr. Corey Washington
|
|
The Caswell Diabetes Institute is pleased to announce our new Managing Director, Corey Washington, PhD. Dr. Washington, who holds doctoral degrees in philosophy and neuroscience, comes to us from Michigan State University, where he served as Director of Analytics and Special Projects in the Office for Research & Innovation for the past seven years. Dr. Washington also has significant experience in management consulting and startup ventures. We look forward to the leadership and energy he will bring to this position and to the Institute in general. Please join us in welcoming Dr. Washington.
Dorene Markel, MS, MHSA, will remain with the Institute for the next 14 months in the new role of Director of Strategy and Special Projects as she begins her phased transition to retirement. She will also continue as the Brehm Center Director during this time.
|
|
Welcome New MDRC and MCDTR Manager of Research Administration
Brenda Phillips
|
|
Please join us in welcoming Brenda Phillips as the new Manager of Research Administration for the MDRC and MCDTR. Brenda will take over from Mary Malec, who will retire on June 4, in overseeing the administration of both centers.
Brenda joined the University of Michigan in 2004, working initially in Financial Operations before moving to the Division of General Medicine in 2008. During her time in General Medicine, Brenda held a broad set of pre-award and post-award responsibilities and will bring a wealth of talent and expertise to her new position with the MDRC and MCDTR. We are delighted to have Brenda aboard!
|
|
Patients hospitalized for COVID-19 are experiencing a broad spectrum of long-term multi-organ issues involving pulmonary, cardiovascular, kidney, metabolic, mood and neurologic complications. Most recently, it’s become apparent that the risk of developing these complications is high even in patients who only experienced mild forms of COVID-19.
Now, to better serve this population, Michigan Medicine is establishing clinics to provide post-discharge care to both adults and pediatric patients experiencing these long-term post COVID symptoms and complications. Read more at Michigan Medicine News
|
|
2021 Clinical Translational Research Scholars Program |
Congratulations to Dr. Yu Kuei Lin on being selected as the 2021 Clinical Translational Research Scholars Program (CTRSP) awardee. Dr. Lin's application, "A Personalized Mobile Health Program for Improving Hypoglycemia Management in Adults with Type 1 Diabetes" set him apart as a promising early career clinical scientist at the University of Michigan.
The CTRSP seeks to identify and support the most promising early-stage scholars focused on clinical research relevant to diabetes. The program provides 50% salary support for up to 3 years, protecting this time from clinical care duties to allow successful clinical research scholarly activities.
|
|
The Caswell Diabetes Institute (CDI) Seminar Series features plenary seminar events addressing the broad interests in diabetes-, obesity-, metabolism-, and complications (DOMC) related research and care across the University of Michigan campus and worldwide. The CDI Seminar Series occurs three times per year in the fall, winter and spring.
The CDI Enrichment Committee is seeking speaker nominations for the 2021-22 academic year. For the fall seminar, we are seeking speaker nominations/ideas to celebrate the 100th anniversary of the discovery of insulin. Please submit your fall nominations by June 20, 2021. For the winter and spring seminars, all ideas are welcome.
To nominate a potential speaker please provide the speaker’s name, affiliation, link to their website, and a short comment on their research topic and how it relates to DOMC-related research and care. Nominations are accepted from all faculty, trainees and staff. Submit your nominations here.
|
|
Check out the latest work from the Soleimanpour Lab, led by Vaibhav Sidarala, on the collaborative role for Mfn 1 and 2 in control of beta cell function and mtDNA content. More
|
|
|
MEND Caswell Diabetes Institute Grand Rounds
|
|
April 30, 2021
Carmella Evans-Molina, MD, PhD
Requires UM login to view
|
|
May 14, 2021
Katharine Garvey, MD, MPH
Requires UM login to view
|
|
|
|
Deadline Approaching: May 28, 2021
The purpose of the MNORC Pilot /Feasibility (P/F) Grant Program is to promote research on the biological and behavioral determinants of obesity, and to develop interventions to reduce obesity and its disease sequelae using basic, clinical, or population approaches. The P/F program’s aim is to enable both new and established University of Michigan investigators to generate sufficient preliminary information for a successful application for major research funding from NIH or other national granting agencies.
|
|
|
|
Deadline: Wednesday, August 4, 2021
|
|
|
|
Deadline: Wednesday, August 4, 2021
|
|
|
|
Deadline: Wednesday, August 4, 2021
|
|
Seeking outstanding candidates with a recent PhD in Biochemistry or a related discipline to work on one of the following funded projects:
- Discovering novel stress-induced ubiquitin and autophagy enzyme interactions in response to glycative stress
- Regulatory mechanisms of eye lens differentiation
- Elucidate interactions between dietary glycemia, metabolomics, microbiome, AMD, cataract, and aging in animal studies and/or human populations, including planning randomized intervention studies
|
|
Postdoctoral Fellowship Opportunity at the University of Colorado
A postdoctoral fellowship opportunity is available in Dr. Minghua Tang’s research team at the University of Colorado Anschutz Medical Campus. This postdoctoral fellow will work primarily on an NIH-funded clinical trial investigating early dietary intakes on infant growth, risk of overweight and gut microbiota development. The trainee is strongly encouraged to apply for the Nutrition T32 fellowship and/or the NIH F32 fellowship in year 2 or 3. For more information contact Minghua.Tang@CUAnschutz.edu | Office: 303-724-3248
|
|
University of Washington Medicine Diabetes Institute (UWMDI) Director
The UWMDI is a multi-disciplinary research institute focused on the prevention and treatment of diabetes mellitus, its complications, and related disorders such as obesity. The UWMDI is seeking a new Director to lead efforts to support and expand basic, translational, and clinical research in these areas. Learn more
|
|
JDRF is seeking a Director of Research. The position requires the skills, vision, and desire to explore and implement novel approaches that will accelerate research and development leading to curative and preventive therapies for T1D. The successful candidate can look forward to interesting and challenging work by building strong relationships with fellow staff and a network of volunteers that will have a meaningful impact on the lives of everyone affected by T1D. Learn more
|
|
About the Elizabeth Weiser Caswell Diabetes Institute
The University of Michigan has outstanding clinicians and researchers in diabetes, metabolic disorders, and their complications. The Elizabeth Weiser Caswell Diabetes Institute serves as the central hub to coordinate these programs. We work across disciplines and serve to integrate rigorous science with patient-centered clinical care to prevent, treat, and ultimately cure diabetes and related disorders.
|
|
Contact Us
Elizabeth Weiser Caswell Diabetes Institute
300 North Ingalls Building
Ann Arbor, Michigan 48109-5405
734-764-4433
Stay Informed
Did you receive this newsletter from a friend? Email us at
to be added to our mailing list.
|
|
|
If you have news items or events of interest to the diabetes, obesity, metabolism and complications community at Michigan, please tell us.
|
|
Supporting the Elizabeth Weiser Caswell Diabetes Institute |
|
Gifts to the Elizabeth Weiser Caswell Diabetes Institute are essential to our mission, to be at the forefront of cutting-edge research and to educate the next generation of leaders to be the best in medicine. Please consider supporting the Elizabeth Weiser Caswell Diabetes Institute: gifts can be made through multiple vehicles such as cash or securities, pledges, payroll deduct, etc. Our development partner, Andrea LaFave is happy to discuss and explore different options with you.
|
|
|
|
|
|
|
